Medicare plans are replacing brand-name buprenorphine-naloxone film with its generic equivalents, resulting in a decrease in out-of-pocket cost faced by enrollees with opioid use disorder. Objectives: ...

DifGen has launched its first complex oral sublingual/buccal film—a generic to Suboxone (Buprenoprhine/Naloxone) in the U.S. market. DifGen also has successfully completed an FDA audit of its ...

Discover what generic brands are, how they differ from store brands, and explore their types, including food and ...

Medicare Part D or Part C plans with drug coverage may cover Suboxone, a medication used to treat opioid use disorder (OUD). If you receive the drug as an inpatient or in a clinic with the help of a ...

U.S. regulators have approved the first generic version of an under-the-tongue film for treating opioid addiction. The Food and Drug Administration on Thursday approved a generic version of Suboxone, ...

Indivior, a pharmaceutical company, has reached a $30 million settlement to resolve a class action lawsuit filed in a U.S. court by health plans. The lawsuit alleges that the company unlawfully ...

(Reuters) - Indivior's U.S. subsidiary has filed lawsuits against firms seeking approval for generic versions of its opioid addiction treatment Suboxone, which generates 80 percent of the drugmaker's ...